Isodiol International (Isodiol International) DeferredTaxAndRevenue : $1.78 Mil (As of Dec. 2019)

View and export this data going back to 2014. Start your Free Trial

What is Isodiol International DeferredTaxAndRevenue?

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Isodiol International's current deferred tax and revenue for the quarter that ended in Dec. 2019 was $1.78 Mil.

Isodiol International DeferredTaxAndRevenue Historical Data

The historical data trend for Isodiol International's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Isodiol International DeferredTaxAndRevenue Chart

Isodiol International Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

DeferredTaxAndRevenue

Get a 7-Day Free Trial

0.32

1.77

Isodiol International Quarterly Data
	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19
DeferredTaxAndRevenue	Get a 7-Day Free Trial															0.22	1.77	1.75	1.77	1.78

Isodiol International DeferredTaxAndRevenue Related Terms

Thank you for viewing the detailed overview of Isodiol International's DeferredTaxAndRevenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Isodiol International (Isodiol International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Isodiol International Inc (OTCPK:ISOLF) » Definitions » DeferredTaxAndRevenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

200 Granville Street, Suite 2710, Vancouver, BC, CAN, V6C 1S4

Website

https://www.isodiol.com

Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.